Literature DB >> 14638771

Conformational epitopes recognized by protective anti-neisserial surface protein A antibodies.

Victor C Hou1, Gregory R Moe, Zyde Raad, Tomi Wuorimaa, Dan M Granoff.   

Abstract

NspA is a conserved membrane protein that elicits protective antibody responses in mice against Neisseria meningitidis. A recent crystallographic study showed that NspA adopts an eight-stranded beta-barrel structure when reconstituted in detergent. In order to define the segments of NspA-containing epitopes recognized by protective murine anti-NspA antibodies, we studied the binding of two bactericidal and protective anti-NspA monoclonal antibodies (MAbs), AL12 and 14C7. Neither MAb binds to overlapping synthetic peptides (10-mers, 12-mers, and cyclic 12-mers) corresponding to the entire mature sequence of NspA, or to denatured recombinant NspA (rNspA), although binding to the protein can be restored by refolding in liposomes. Based on the ability of the two MAbs to bind to Escherichia coli microvesicles prepared from a set of rNspA variants created by site-specific mutagenesis, the most important contacts between the MAbs and NspA appear to be located within the LGG segment of loop 3. The conformation of loop 2 also appears to be an important determinant, as particular combinations of residues in this segment resulted in loss of antibody binding. Thus, the two anti-NspA MAbs recognize discontinuous conformational epitopes that result from the close proximity of loops 2 and 3 in the three-dimensional structure of NspA. The data suggest that optimally immunogenic vaccines using rNspA will require formulations that permit proper folding of the protein.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14638771      PMCID: PMC308938          DOI: 10.1128/IAI.71.12.6844-6849.2003

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  21 in total

1.  Meningococcal disease in Europe: epidemiology, mortality, and prevention with conjugate vaccines. Report of a European advisory board meeting Vienna, Austria, 6-8 October, 2000.

Authors:  K Cartwright; N Noah; H Peltola
Journal:  Vaccine       Date:  2001-08-14       Impact factor: 3.641

2.  Crystal structure of the OpcA integral membrane adhesin from Neisseria meningitidis.

Authors:  Stephen M Prince; Mark Achtman; Jeremy P Derrick
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-12       Impact factor: 11.205

Review 3.  Meningococcal disease.

Authors:  N E Rosenstein; B A Perkins; D S Stephens; T Popovic; J M Hughes
Journal:  N Engl J Med       Date:  2001-05-03       Impact factor: 91.245

4.  A novel mimetic antigen eliciting protective antibody to Neisseria meningitidis.

Authors:  D M Granoff; G R Moe; M M Giuliani; J Adu-Bobie; L Santini; B Brunelli; F Piccinetti; P Zuno-Mitchell; S S Lee; P Neri; L Bracci; L Lozzi; R Rappuoli
Journal:  J Immunol       Date:  2001-12-01       Impact factor: 5.422

5.  Differences in surface expression of NspA among Neisseria meningitidis group B strains.

Authors:  G R Moe; S Tan; D M Granoff
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

6.  Modification of lipid A biosynthesis in Neisseria meningitidis lpxL mutants: influence on lipopolysaccharide structure, toxicity, and adjuvant activity.

Authors:  P van der Ley; L Steeghs; H J Hamstra; J ten Hove; B Zomer; L van Alphen
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

Review 7.  Vaccine prevention of meningococcal disease, coming soon?

Authors:  S L Morley; A J Pollard
Journal:  Vaccine       Date:  2001-12-12       Impact factor: 3.641

Review 8.  Development of vaccines against meningococcal disease.

Authors:  Luis Jódar; Ian M Feavers; David Salisbury; Dan M Granoff
Journal:  Lancet       Date:  2002-04-27       Impact factor: 79.321

9.  The changing epidemiology of meningococcal disease in the United States, 1992-1996.

Authors:  N E Rosenstein; B A Perkins; D S Stephens; L Lefkowitz; M L Cartter; R Danila; P Cieslak; K A Shutt; T Popovic; A Schuchat; L H Harrison; A L Reingold
Journal:  J Infect Dis       Date:  1999-12       Impact factor: 5.226

10.  Functional activity of anti-Neisserial surface protein A monoclonal antibodies against strains of Neisseria meningitidis serogroup B.

Authors:  G R Moe; P Zuno-Mitchell; S S Lee; A H Lucas; D M Granoff
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

View more
  16 in total

1.  Role of Gonococcal Neisserial Surface Protein A (NspA) in Serum Resistance and Comparison of Its Factor H Binding Properties with Those of Its Meningococcal Counterpart.

Authors:  Lisa A Lewis; Peter A Rice; Sanjay Ram
Journal:  Infect Immun       Date:  2019-01-24       Impact factor: 3.441

2.  Characterization of MspA, an immunogenic autotransporter protein that mediates adhesion to epithelial and endothelial cells in Neisseria meningitidis.

Authors:  D P J Turner; A G Marietou; L Johnston; K K L Ho; A J Rogers; K G Wooldridge; D A A Ala'Aldeen
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

3.  The relative roles of factor H binding protein, neisserial surface protein A, and lipooligosaccharide sialylation in regulation of the alternative pathway of complement on meningococci.

Authors:  Lisa A Lewis; Matthew Carter; Sanjay Ram
Journal:  J Immunol       Date:  2012-04-13       Impact factor: 5.422

4.  Comparative proteome analysis of spontaneous outer membrane vesicles and purified outer membranes of Neisseria meningitidis.

Authors:  Martin Lappann; Andreas Otto; Dörte Becher; Ulrich Vogel
Journal:  J Bacteriol       Date:  2013-07-26       Impact factor: 3.490

Review 5.  Review of meningococcal group B vaccines.

Authors:  Dan M Granoff
Journal:  Clin Infect Dis       Date:  2010-03-01       Impact factor: 9.079

6.  Neisseria gonorrhoeae NspA induces specific bactericidal and opsonic antibodies in mice.

Authors:  Guocai Li; Hongmei Jiao; Guihua Jiang; Jing Wang; Litian Zhu; Rushan Xie; Hua Yan; Hongju Chen; Mingchun Ji
Journal:  Clin Vaccine Immunol       Date:  2011-09-14

7.  Expression of heterologous antigens in commensal Neisseria spp.: preservation of conformational epitopes with vaccine potential.

Authors:  Clíona A O'dwyer; Karen Reddin; Denis Martin; Stephen C Taylor; Andrew R Gorringe; Michael J Hudson; Bernard R Brodeur; Paul R Langford; J Simon Kroll
Journal:  Infect Immun       Date:  2004-11       Impact factor: 3.441

8.  posttranslational modification of recombinant Plasmodium falciparum apical membrane antigen 1: impact on functional immune responses to a malaria vaccine candidate.

Authors:  Birgitte Giersing; Kazutoyo Miura; Richard Shimp; Jin Wang; Hong Zhou; Andrew Orcutt; Anthony Stowers; Allan Saul; Louis H Miller; Carole Long; Sanjay Singh
Journal:  Infect Immun       Date:  2005-07       Impact factor: 3.441

9.  Impaired Immunogenicity of Meningococcal Neisserial Surface Protein A in Human Complement Factor H Transgenic Mice.

Authors:  Eduardo Lujan; Rolando Pajon; Dan M Granoff
Journal:  Infect Immun       Date:  2015-11-23       Impact factor: 3.441

10.  Specificity of subcapsular antibody responses in Ethiopian patients following disease caused by serogroup A meningococci.

Authors:  Gunnstein Norheim; Abraham Aseffa; Mohammed Ahmed Yassin; Getahun Mengistu; Afework Kassu; Dereje Fikremariam; Wegene Tamire; Yared Merid; E Arne Høiby; Dominique A Caugant; Elisabeth Fritzsønn; Torill Tangen; Berhanu Melak; Degu Berhanu; Morten Harboe; Jan Kolberg; Einar Rosenqvist
Journal:  Clin Vaccine Immunol       Date:  2008-03-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.